GHRP-6 Dosing Protocol: 2 mg Vial — Starter Dosing Guide & Supplies

GHRP-6 Dosing Protocol: 2 mg Vial — Starter Dosing Guide & Supplies

Quickstart highlights

GHRP-6 is a hexapeptide ghrelin receptor agonist with the strongest appetite-stimulating properties among commonly used GHRPs, due to its partial gastric motility effects in addition to central ghrelin receptor binding.

  • Concentration: 2 mg/mL (2 mg vial + 1 mL bacteriostatic water).
  • At 2 mg/mL: 100 µg = 5 units, 200 µg = 10 units.
  • 2 mg vial provides 20 doses at 100 µg — ideal starter size to assess hunger tolerance.
  • GHRP-6 causes significant appetite stimulation within 30 minutes; plan meals accordingly.
  • Refrigerate; use within 28 days.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-210051–2x daily (fasted)100 µg — 5 units; 2 mg vial provides 20 doses at this level; test hunger response
3-4200101–3x daily (fasted)200 µg — 10 units; 10 doses per vial; move to 5 mg vial for continued use

Your free GHRP-6 tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Add your listing Already have one? Sign in

Reconstitution steps

  1. Draw 1 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until powder dissolves; do not shake.
  3. Final concentration: 2 mg/mL. At 2 mg/mL: 1 unit = 20 µg.
  4. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

4-week plan

  • 2 vials
  • 28 syringes
  • 2 mL bac water
  • 28 alcohol swabs
Need clinics? See vetted providers →
Advertisement

Protocol overview & cycle notes

Assess GHRP-6 GH secretagogue response and hunger tolerance using the compact 2 mg starter vial before committing to a full 5 mg or 10 mg vial cycle.

Cycle length: 4 weeks on.

Off-cycle: 2–4 weeks off after 4-week starter cycle; progress to 5 mg vial for full protocol.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 2 mg/mL: refrigerate 2–8 °C; use within 28 days. The 2 mg vial is a trial size — plan to transition to 5 mg or 10 mg vials for extended cycles.

Injection & tracking tips

  • GHRP-6 causes significant hunger within 20–30 minutes post-injection; plan injections immediately before a planned meal if appetite stimulation is desired.
  • The 2 mg vial is recommended for first-time GHRP-6 users to assess hunger sensitivity before committing to larger supplies.
  • Inject subcutaneously in the abdomen, 2 inches from the navel.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Track hunger level (0–10) for 60 minutes post-injection to assess ghrelin-mediated appetite response.
  • Weigh yourself daily for the first week to monitor water retention from GH elevation.
  • Log sleep quality nightly if injecting at bedtime.
Log your cycle in the calculator →

How this works & references

GHRP-6 is a hexapeptide ghrelin receptor agonist with the strongest appetite-stimulating properties among commonly used GHRPs, due to its partial gastric motility effects in addition to central ghrelin receptor binding. GH pulse amplitudes are comparable to GHRP-2 at equivalent doses, but pronounced hunger (reported by ~80% of users) distinguishes it from ipamorelin and GHRP-2.

Frequently asked questions

Why is GHRP-6 known for causing extreme hunger?
GHRP-6 activates ghrelin receptors in the hypothalamic NPY/AgRP neurons and also affects gastric motility via vagal ghrelin pathways. The hunger response peaks 20–30 minutes post-injection and subsides within 60–90 minutes. This can be used therapeutically in underweight or anorexic patients.
Is the 2 mg vial cost-effective?
The 2 mg vial is only recommended for initial tolerance testing. At 200 µg 2x daily, a 2 mg vial lasts 5 days — insufficient for even a 1-week trial. Transition to the 5 mg or 10 mg vial for practical use.
Can GHRP-6 be used for appetite stimulation in medical settings?
GHRP-6 has been studied for cachexia (cancer, AIDS wasting, anorexia). Its ghrelin-mimetic appetite stimulation is more pronounced than GHRP-2 or ipamorelin. Formal clinical approval for this indication does not exist in the US, but research use in compounding protocols exists.
How does GHRP-6 affect cortisol compared to GHRP-2?
GHRP-6 produces cortisol and prolactin elevation comparable to GHRP-2 at equivalent doses (approximately 20–40% above baseline at 200 µg). Neither is cortisol-neutral; ipamorelin remains the preferred choice when cortisol elevation is a concern.
Should I move to a larger vial after the 2 mg trial?
Yes — if GHRP-6 is well-tolerated after the 2 mg trial (acceptable hunger response, no significant GI distress), the 5 mg vial (25 doses at 200 µg) or 10 mg vial (50 doses at 200 µg) is appropriate for a full 4–12 week cycle.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.